Improving Treatment and Early Diagnosis of Retinoblastoma in Children Up to 18 Years in African Settings

What this Trial Is About

This research aims to improve outcomes for children with retinoblastoma, a type of eye cancer, particularly in low-income African countries where survival rates are lower compared to high-income countries. The study focuses on children with stage II disease and hopes that early diagnosis and timely treatment can greatly enhance survival. This is an observational study designed to collect and analyze data on disease stage, treatments used, and patient outcomes over time. The study follows therapeutic recommendations for treating children diagnosed with retinoblastoma. It observes how well these treatment protocols are implemented and whether they lead to better survival rates. The study does not involve administering experimental treatments but monitors the treatments given according to these recommendations. Participants will be monitored and followed for up to 10 years to assess various outcomes, including the number of retinoblastoma cases at participating hospitals, the number of cases at stage II disease, the feasibility of applying these therapeutic recommendations in the African setting, and treatment evaluations. Follow-up care and data collection will support understanding the effectiveness and practicality of early diagnosis and treatment in improving survival.

Therapeutic Recommendations For The Treatment Of Children With A Retinoblastoma